Heart Disease News and Research

Latest Heart Disease News and Research

NCKU Assistant Professor receives prestigious Ting Nong Award

Dr. Ping-Yen Liu, the Assistant Professor of Internal Medicine at National Cheng Kung University (NCKU) and Attending Physician of National Cheng-Kung University Hospital, Taiwan, received Ting Nong Award from Taiwan Society of Cardiology.

28 May 2010

Stanford Hospital & Clinics uses endovascular laser technology to retrieve permanently embedded IVC filters

Over the years, Susan Karnstedt had gotten used to the intermittent pain in her abdomen, chalking it up to her diet, or perhaps to her physically active lifestyle, as a water skier and yoga enthusiast.

28 May 2010

CREST: Carotid artery surgery and stenting have long-term outcomes for patients with stroke

Physicians now have two safe and effective options to treat their patients at risk for stroke, says a researcher at Mayo Clinic who led a large, NIH-funded, national clinical trial testing surgery or use of a stent to open a blocked carotid artery.

28 May 2010

Cardiac biomarkers help nephrologists manage fluid overload in dialysis patients: Study

Nephrologists must consider fluid overload effects when prescribing dialysis, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology. The fluid overload biomarker, N-terminal pro-brain-type natriuretic peptide, previously known as a "cardiac biomarker" in dialysis patients, is an important component of managing patients with kidney disease.

28 May 2010

New surgical procedure improves survival in infants with severely underdeveloped hearts

Pediatric researchers report that a recently introduced surgical procedure offers infants with severely underdeveloped hearts a better chance at surviving during their first year of life in comparison to the standard surgery.

28 May 2010

BG Medicine announces data presentations on galectin-3 at Heart Failure Congress 2010

BG Medicine, Inc., a U.S. based, privately-held biomarker discovery and in vitro diagnostics company, announced today that there will be several data presentations regarding galectin-3 at the Heart Failure Congress 2010, the annual scientific meeting of the Heart Failure Association of the European Society of Cardiology, to be held in Berlin, Germany, on May 29th through June 1st. BG Medicine has developed and applied for FDA clearance of an in vitro diagnostic test to measure galectin-3 levels in plasma or serum.

28 May 2010

BTE awards Diabetes Care Recognition Program certificates to 118 Montefiore Medical Group physicians

Bridges to Excellence, a national program that recognizes and rewards physicians for delivering better quality care, today awarded its sought-after Diabetes Care Recognition Program certificate to the 118 physicians in Montefiore Medical Center's 20 outpatient care facilities, known as the Montefiore Medical Group, for substantially lowering blood sugar levels and "bad" cholesterol levels in thousands of adult patients with diabetes.

28 May 2010

Children's Hospital of Philadelphia announces availability of proton therapy at Roberts Proton Therapy Center

The Children's Hospital of Philadelphia announces the availability of proton therapy, a precise form of cancer radiation that offers potentially life-changing benefits to children with brain tumors and other solid tumors. The Hospital's Cancer Center has recently begun using proton treatment at the new Roberts Proton Therapy Center, a cutting-edge radiation oncology facility located across the street from Children's Hospital in Penn Medicine's Perelman Center for Advanced Medicine.

28 May 2010

State-of-the-art heart pump lowers risk for infection in end-stage cardiac patients: Researchers

A state-of-the-art heart pump recently approved for use in end-stage cardiac patients has a significantly lower risk for infection than an earlier model of the device, according to researchers at Henry Ford Hospital in Detroit.

28 May 2010

Restricting salt intake helps control blood pressure in dialysis patients: Research

For kidney patients trying to control their blood pressure, reducing fluid build-up in the blood is more effective than using antihypertensive medications, according to an analysis appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

28 May 2010

IPS Research joins SAFE-BioPharma Association

IPS Research Company, a major southwest clinical research investigator site located in Oklahoma City, OK, has joined SAFE-BioPharma Association and taken another step in the process of eliminating paper copies from its operations.

28 May 2010

Regulus Therapeutics obtains rights to intellectual property covering methods for modulating microRNA-21

Regulus Therapeutics Inc. announced today that it has obtained exclusive rights from the University of Wuerzburg to intellectual property covering methods for modulating microRNA-21. Regulus scientists and collaborators have shown that microRNA-21, (miR-21), is dysregulated in mouse models of cardiac disease and fibrosis, and that antagonizing miR-21 with therapeutic oligonucleotides targeting miR-21 inhibits fibrosis and attenuates cardiac function in such models. Regulus is currently developing a microRNA therapeutic targeting miR-21 as an anti-fibrotic therapy.

28 May 2010

Individuals with poor oral hygiene at increased risk of heart disease

Individuals who have poor oral hygiene have an increased risk of heart disease compared to those who brush their teeth twice a day, finds research published today on BMJ.com.

28 May 2010

OHSU partners with UO, Harvard to expedite research into compounds that may prevent Fanconi anemia

Oregon Health & Science University is partnering with the University of Oregon and Harvard Medical School to expedite basic science research into new and existing drugs and compounds that may prevent the complications associated with Fanconi anemia, an inherited condition that can lead to bone marrow failure and cancer.

28 May 2010

PCA-Rx represents next generation of chelation technology for ASD patients

According to the Center for Disease Control, autism has risen to an epidemic rate of 1 in 100 in the U.S., up from 1 in 150 in 2007. While controversy looms regarding its cause, many parents of autistic children believe a correlation exists with toxin accumulation. To give autism spectrum disorder sufferers a natural alternative to chelation therapy, Maxam Nutraceutics has introduced PCA-Rx.

28 May 2010

Zargis Medical launches live-streaming version of Telemed platform at ATA

Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp., today announced that it launched the live-streaming version of its ZargisTelemed™ platform at last week's American Telemedicine Association Conference (ATA) in San Antonio, TX. The system allows healthcare professionals to share stethoscope sounds in real-time with colleagues located anywhere in the world through the Internet or a private network. This technology is cleared for sale in the U.S. and 36 other countries.

28 May 2010

CompuMed's digital telemedicine technologies incorporated in Visio Mobile Diagnostics' healthcare services suite

CompuMed, Inc., a telemedicine and medical informatics company, reported its CardioGram® and OsteoGram® systems have been incorporated as core components of Visio Mobile Diagnostics' suite of telemedicine and digital x-ray-based healthcare services.

27 May 2010

HeartMate II left ventricular assist device also improves right side heart function

A state-of-the-art heart pump, designed to maintain a continuous flow of blood in end-stage cardiac patients with damage to the left side of the heart, also improves function on the right side of the heart, according to researchers at Henry Ford Hospital's Heart and Vascular Institute.

27 May 2010

Bio-Reference Laboratories second-quarter revenues up 27% to $110,447,000

Bio-Reference Laboratories, Inc. (Numbers in Thousands Except Per Share Data or where otherwise noted) released its second quarter, fiscal year 2010 earnings today for the three months ending April 30. The Company recorded current quarter revenues of $110,447, the best ever quarter in corporate history and an increase of 27% over the $87,183 recorded in the second quarter, fiscal year 2009.

27 May 2010

National Science Foundation supports PolyMedix with $150,000 grant for development of antimicrobial sutures

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat serious acute cardiovascular disorders and infectious diseases, has received a grant in the amount of $150,000 from the National Science Foundation to support the development of antimicrobial sutures. PolyMedix has developed a series of novel antimicrobial polymers for device and material applications, which it collectively calls the PolyCides™.

27 May 2010

Heart Disease News and Research

Latest Heart Disease News and Research

NCKU Assistant Professor receives prestigious Ting Nong Award

Stanford Hospital & Clinics uses endovascular laser technology to retrieve permanently embedded IVC filters

CREST: Carotid artery surgery and stenting have long-term outcomes for patients with stroke

Cardiac biomarkers help nephrologists manage fluid overload in dialysis patients: Study

New surgical procedure improves survival in infants with severely underdeveloped hearts

BG Medicine announces data presentations on galectin-3 at Heart Failure Congress 2010

BTE awards Diabetes Care Recognition Program certificates to 118 Montefiore Medical Group physicians

Children's Hospital of Philadelphia announces availability of proton therapy at Roberts Proton Therapy Center

State-of-the-art heart pump lowers risk for infection in end-stage cardiac patients: Researchers

Restricting salt intake helps control blood pressure in dialysis patients: Research

IPS Research joins SAFE-BioPharma Association

Regulus Therapeutics obtains rights to intellectual property covering methods for modulating microRNA-21

Individuals with poor oral hygiene at increased risk of heart disease

OHSU partners with UO, Harvard to expedite research into compounds that may prevent Fanconi anemia

PCA-Rx represents next generation of chelation technology for ASD patients

Zargis Medical launches live-streaming version of Telemed platform at ATA

CompuMed's digital telemedicine technologies incorporated in Visio Mobile Diagnostics' healthcare services suite

HeartMate II left ventricular assist device also improves right side heart function

Bio-Reference Laboratories second-quarter revenues up 27% to $110,447,000

National Science Foundation supports PolyMedix with $150,000 grant for development of antimicrobial sutures

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Heart Disease News and Research

Latest Heart Disease News and Research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in